AKT1 and cancer: Shi et al. (2015) utilized a xenograft BALB/c athymic nude mouse model to demonstrate that pretreatment of animals with EGCG subcutaneously at 100 μM effectively reduced cancer cell proliferation by suppression of nicotine-induced Akt and ERK1/2 signaling [206].